PDS Biotechnology Corp
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $-50.9M | $-38.8M | $-28.1M | $-12.2M | $-6.9M |
| Depreciation & Amortization | — | — | — | — | — |
| Depreciation | $182.9K | $100.1K | $53.1K | $31.2K | $4.4K |
| Amortization | — | — | — | — | — |
| Stock-Based Compensation | $6.2M | $5.3M | $2.9M | $1.3M | $260.4K |
| Net Cash from Operating Activities | $-40.7M | $-32.2M | $-21.8M | $-9.7M | $-8.0M |
| Investing Activities | |||||
| Capital Expenditures | $188.7K | $686.7K | $1.3M | $884.8K | $136.9K |
| Business Acquisitions | — | — | — | — | — |
| Net Cash from Investing Activities | $-188.7K | $-686.7K | $-1.3M | — | — |
| Financing Activities | |||||
| Dividends Paid | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — |
| Net Cash from Financing Activities | $22.6M | $9.1M | $139.5M | — | — |
| Net Change in Cash | $-18.3M | $-23.8M | $116.5M | $5.9M | $7.7M |
| Free Cash Flow | $-40.9M | $-32.9M | $-23.1M | $-10.6M | $-8.2M |